Skip to main content
OpenTrials
Completed

NCT Number: NCT01667354

Vaccine Hesitancy Intervention--Provider (VHIP)

The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Childhood Vaccination

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Group Health Research Institute

Seattle, Washington, 98101, United States

About this study

The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy. The investigators will train primary care teams with an initial training followed by telephone coaching and follow-up visits, and assess the outcomes of parental vaccine hesitancy (primary) and physician self-efficacy (secondary) at baseline and 6 months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Study population:

  • Eligible pediatric and family medicine practices in three counties in Washington State; King, Pierce and Snohomish Counties.
  • Mothers whose infants will receive care in participating clinics.

Inclusion Clinics:

  • Located in King, Snohomish, Pierce Counties, WA;
  • Family practice clinics;
  • Pediatric practice clinics;
  • Order > 1000 doses of vaccine in 2009 from State of Washington Department of Health.

Exclusion Clinics: Not willing to be randomized.

Inclusion Mothers:

  • Babies born at participating hospitals;
  • Mother can be recruited before discharged post-birth;
  • Mothers declare pediatric care at one of participating clinics;
  • Singleton or twin pregnancies.

Exclusion Mothers:

  • Babies born < 36 weeks gestational age;
  • Known medical vaccine contraindications;
  • Parental age < 18;
  • NICU;
  • Triplet or more;
  • Maternal complications.

Treatment and study plan

academic detailing

Behavioral

The intervention design is based on "academic detailing," an effective method of changing physician behavior. The aim of the training is effective communication with parents who are hesitant about childhood vaccinations.

Primary outcomes

  1. Parental Vaccine Hesitancy Measure

    Time frame: Change from Baseline in Parental Hesitancy at 6 months

    The investigators will contact mothers of newborns in study practices and conduct a telephone survey at two time points: baseline and 6 months. Surveys will assess parental hesitancy, parental trust in provider, and other covariates such as perceived social norms, other sources of information about vaccines, and demographic information.

Secondary outcomes

  1. Physician Self Efficacy Measure

    Time frame: Change from Baseline in Physician Attitudes at 6 months

    Assessed via self-administered surveys of providers in all participating clinics at baseline and 6-months. The investigators will measure physician attitudes, perceived norms, intentions to change behavior, practice characteristics, and physician demographics.

Sponsors and collaborators

Lead sponsor

Kaiser Permanente

Other

Collaborators

  • Seattle Children's Hospital
  • Washington State, Department of Health
  • WithinReach

Registry information

Acronym: VHIP

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Aug 17, 2012
Registry last updated
Oct 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.